Individualizing the risks and benefits of postmenopausal hormone therapy.

OBJECTIVE: The objective was to develop an individualized risk-benefit model quantifying the impact of combined use of estrogen and progestogen on chronic diseases. DESIGN: The study population consisted of women, aged 40+, prescribed postmenopausal hormone therapy (HT) in the UK General Practice Re...

תיאור מלא

מידע ביבליוגרפי
Main Authors: van Staa, T, Cooper, C, Barlow, D, Leufkens, H
פורמט: Journal article
שפה:English
יצא לאור: 2008